The Nasdaq Stock Market® Welcomes 14 New ETPs in the Second Quarter of 2017
Powered by WPeMatico
Biotech Stocks Feel the Wrath of Trump
Wall Street Journal
Health-care investors got an ugly preview Wednesday of what the next four years might look like. President-elect Donald Trump said during a news conference that the pharmaceuticals industry is “getting away with murder,” and vowed the U.S. government, ...
Trump says drugmakers are 'getting away with murder,' and biotech stocks plungeCNBC
Market Challenge: Biotech Under PressureSeeking Alpha
Philadelphia-Area Biotech Stocks Hammered in Wake of Trump CommentsNBC 10 Philadelphia
Fortune -WBUR -Boston Business Journal -NPR
all 133 news articles »
Large Cap Biotech Review Pre-Earnings, Part 2
The large cap biotech sector now has a large diversity of names, dividend policies, and therapeutic foci. In Part 1, published Tuesday, and this article, I have tried to provide thumbnail comments on the stocks I follow as I prepare for earnings season.